Phase I/II study of a combination of capecitabine, cisplatin, and intraperitonealdocetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis

被引：0
|
作者：
Cho, Hyungwoo
Ryu, Min-Hee
Yoo, Changhoon
Ryoo, Baek-Yeol
Park, Sook Ryun
Kim, Kyu-Pyo
Kim, Beom Su
Yoo, Moon-Won
Yook, Jeong Hwan
Kim, Byung Sik
Kang, Yoon-Koo
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[5] Asan Med Ctr, Dept Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4026
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [22] A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results
    Yun, J. A.
    Kong, J. H.
    Kim, J. A.
    Lee, S. H.
    Lee, J. Y.
    Park, S. H.
    Park, J. O.
    Park, Y. S.
    Lim, H. Y.
    Kang, W. K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 363 - 363
  • [23] Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
    Vatandoust, Sina
    Bright, Tim
    Roy, Amitesh Chandra
    Watson, David
    Gan, Susan
    Bull, Jeff
    Abbas, Muhammad Nazim
    Karapetis, Christos Stelios
    BMJ OPEN, 2019, 9 (05):
  • [24] Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
    Ryu, Min-Hee
    Yoo, Changhoon
    Kim, Jong Gwang
    Ryoo, Baek-Yeol
    Park, Young Soo
    Park, Sook Ryun
    Han, Hye-Suk
    Chung, Ik Joo
    Song, Eun-Kee
    Lee, Kyung Hee
    Kang, Seok Yun
    Kang, Yoon-Koo
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (04) : 482 - 488
  • [25] Phase II study of capecitabine in combination with cisplatin in advanced head and neck cancer: preliminary results
    Lorusso, V
    Calvi, N.
    Ciccarese, M.
    Romano, G.
    Palumbo, A.
    Bonaduce, S.
    Santantonio, M.
    Latorre, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 191 - 191
  • [26] Phase II study of capecitabine in combination with cisplatin in advanced head and neck cancer: Preliminary results
    Lorusso, V.
    Calvi, N.
    Ciccarese, M.
    Romano, G.
    Palumbo, A.
    Bonaduce, S.
    Santantonio, M.
    Latorre, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] A PHASE II STUDY WITH CAPECITABINE AND CISPLATIN AS FIRST-LINE THERAPY IN ADVANCED GASTRIC CANCER
    Fonseca, P. J.
    Vieitez, J. M.
    Frunza, M.
    Berros, J. P.
    Fernandez De Sanmamed, M.
    Muriel, C.
    Izquierdo, M.
    Pardo, P.
    Gutierrez, E.
    Lacave, A. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 240 - 240
  • [28] A phase II study with capecitabine and cisplatin as first-line therapy in advanced gastric cancer
    Jimenez-Fonseca, P.
    Vieitez, J.
    Crespo, G.
    Berros, J.
    Fernandez De Sanmamed, M.
    Muriel, C.
    Jimenez-Lacave, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 45 - 46
  • [29] A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
    Brenner, Baruch
    Sarfaty, Michal
    Purim, Ofer
    Kundel, Yulia
    Amit, Limor
    Abramovich, Amir
    Gonik, Udi Sadeh
    Idelevich, Efraim
    Gordon, Noa
    Medalia, Gal
    Sulkes, Aaron
    PLOS ONE, 2016, 11 (07):
  • [30] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, Chul
    Lee, Jae-Lyun
    Choi, Yoon Hee
    Kang, Byung Woog
    Ryu, Min-Hee
    Chang, Heung Moon
    Kim, Tae Won
    Kang, Yoon-Koo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 306 - 315
12345